Your shopping cart is currently empty

Akt/NF-κB/MAPK-IN-1 (compound 2m) is a potent, orally active inhibitor of NO with an IC50 of 7.70 μM and low toxicity, exhibiting anti-inflammatory effects by blocking the Akt/NF-κB and MAPK signaling pathways [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Akt/NF-κB/MAPK-IN-1 (compound 2m) is a potent, orally active inhibitor of NO with an IC50 of 7.70 μM and low toxicity, exhibiting anti-inflammatory effects by blocking the Akt/NF-κB and MAPK signaling pathways [1]. |
| In vitro | Akt/NF-κB/MAPK-IN-1 (compound 2m) at concentrations of 0 to 20 μM over 24 hours significantly reduced TNF-α, IL-1β, IL-6, and PGE2 levels, and downregulated iNOS and COX-2 expression in LPS (10 ng/mL)-stimulated RAW264.7 cells. Additionally, it inhibited p38, ERK, and JNK phosphorylation in LPS-induced RAW264.7 cells [1]. |
| In vivo | Akt/NF-κB/MAPK-IN-1 (compound 2m), administered orally at 10-20 mg/kg for 7 consecutive days, alleviates LPS-induced inflammatory disease in mice [1]. |
| Molecular Weight | 604.86 |
| Formula | C38H56N2O4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.